Healthcare


Analysis of the European HIV Drugs Market

Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth
Share this:
     
Published: 23 Jan 2013

This research service provides an in-depth analysis of the HIV drugs market across Europe. It analyses the revenue potential, market dynamics, trends, and the competitive structure. The revenue values of the European HIV drugs market have been derived from market sales and pipeline investment made under drug classes like nucleoside reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and integrase inhibitors. The market analysed in this research service has been approached from a manufacturer's point of view. Apart from segmentation by drug classes, the market has also been broken down based on major Western European countries.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
  11.  
  12.  
  13.  
  14.  
  15.  
  16.  
  17.  
  18.  
  19.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..